_edited.png)
Isolation of Circulating Tumor Cells (CTCs) for Cancer Diagnostics
The Cell Isolation Market is rapidly advancing with technologies that enable the efficient isolation of circulating tumor cells (CTCs) from blood samples. CTCs are rare cancer cells shed from primary or metastatic tumors into the bloodstream and serve as critical biomarkers for early cancer detection, prognosis, and treatment monitoring.
Isolation of CTCs poses significant challenges due to their extremely low abundance among billions of blood cells. Cutting-edge techniques combine microfluidics, immunoaffinity capture, and size-based separation to enrich and isolate these rare cells with high sensitivity and specificity. The ability to analyze CTCs non-invasively provides oncologists with valuable insights into tumor biology, enabling personalized therapeutic strategies and improved patient outcomes.